Compare BAM & MO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BAM | MO |
|---|---|---|
| Founded | 2022 | 1822 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | | Medicinal Chemicals and Botanical Products |
| Sector | | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 86.6B | 98.6B |
| IPO Year | N/A | N/A |
| Metric | BAM | MO |
|---|---|---|
| Price | $51.73 | $61.01 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 8 |
| Target Price | ★ $63.07 | $60.57 |
| AVG Volume (30 Days) | 1.7M | ★ 9.5M |
| Earning Date | 02-04-2026 | 01-29-2026 |
| Dividend Yield | 3.43% | ★ 6.94% |
| EPS Growth | ★ 42.52 | N/A |
| EPS | 1.62 | ★ 5.24 |
| Revenue | $4,486,000,000.00 | ★ $20,166,000,000.00 |
| Revenue This Year | $34.55 | $1.44 |
| Revenue Next Year | $14.14 | N/A |
| P/E Ratio | $31.50 | ★ $11.65 |
| Revenue Growth | ★ 10.85 | N/A |
| 52 Week Low | $41.78 | $50.08 |
| 52 Week High | $64.10 | $68.60 |
| Indicator | BAM | MO |
|---|---|---|
| Relative Strength Index (RSI) | 44.58 | 62.66 |
| Support Level | $50.36 | $60.26 |
| Resistance Level | $53.25 | $62.08 |
| Average True Range (ATR) | 1.34 | 1.19 |
| MACD | -0.27 | 0.48 |
| Stochastic Oscillator | 25.42 | 86.10 |
Brookfield Asset Management is one of the world's largest alternative-asset managers, with USD 1.151 trillion in total managed assets, including USD 580.7 billion in fee-earning AUM, at the end of September 2025. The company has three main business segments: private credit (USD 349.0 billion in total AUM and USD 262.8 billion in fee-earning AUM), private equity (USD 151.0 billion/USD 46.3 billion), and real estate/real assets (USD 651.0 billion/USD 271.6 billion). The firm primarily serves institutional investors (90% of AUM) and high-net-worth individuals (10%), and is diversified globally, with 67% of revenue from the Americas, 20% from EMEA, and 13% from Asia-Pacific. Canadian-based Brookfield Corporation owns 73% of Brookfield's outstanding Class A shares.
Altria comprises Philip Morris USA, US Smokeless Tobacco, John Middleton, Horizon Innovations, and Helix Innovations. Through its tobacco subsidiaries, Altria maintains the leading position in cigarettes and smokeless tobacco in the United States and the number-two spot in machine-made cigars. The company's Marlboro brand is the leading cigarette brand in the US with 42% annual share in 2024. Beyond its core business, it holds an 8% interest in the world's largest brewer, Anheuser-Busch InBev and a 41% stake in cannabis manufacturer Cronos. It also acquired vaping company Njoy Holdings in 2023 and operates a joint venture with Japan Tobacco in the heated tobacco category for the US.